GSK is expected to report earnings to fall 39.99% to 66 cents per share on July 27
Q2'22
Est.
$0.67
Q2'24
Beat
by $0.13
Q1'24
Beat
by $0.16
Q4'23
Est.
$0.74
Q3'23
Missed
by $0.60
The last earnings report on July 31 showed earnings per share of $1.11, beating the estimate of 97 cents. With 3.14M shares outstanding, the current market capitalization sits at 88.13B.